# OnCo record araris (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/araris/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "araris" ;
  schema:name "Araris Biotech (Taiho)"@en ;
  schema:description "Swiss linker-technology company (AraLinQ) acquired by Taiho for up to $1.14B; first clinical ADC ARC-02 (CD79b) dosed in June 2026."@en ;
  schema:url <https://onco.cc/companies/araris/>, <https://www.ararisbiotech.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://www.taiho.co.jp/en/release/2026/20260428.html> ;
  schema:addressCountry "CH" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/> ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/site-specific-conjugation/> ;
  onco:trials <https://onco.cc/trials/nct02503423/>, <https://onco.cc/trials/nct07710885/>, <https://onco.cc/trials/nct05945823/>, <https://onco.cc/trials/nct04256317/>, <https://onco.cc/trials/nct04683250/>, <https://onco.cc/trials/nct05727176/>, <https://onco.cc/trials/nct05967689/> .